1. Home
  2. News Releases
  3. Back Issues
  4. October FY2020
  5. COVID-19 Testing Center for Overseas Travelers (TeCOT) to Additionally Start Provision of Services to Short-Term Overseas Business Travelers Having Returned to Japan

COVID-19 Testing Center for Overseas Travelers (TeCOT) to Additionally Start Provision of Services to Short-Term Overseas Business Travelers Having Returned to Japan

October 30, 2020

The COVID-19 Testing Center for Overseas Travelers (TeCOT) is a system in which the government supports business overseas travelers in receiving services for smoothly obtaining a certification for a negative result of a medical test concerning the novel coronavirus disease, a document necessary for entering their destination countries or other purposes. Since its inauguration, TeCOT has only been targeting overseas business travelers who need to undergo a medical test before leaving Japan.

However, in response to the decision by the government of Japan on new measures for resuming cross-border travel, TeCOT will additionally start provision of services concerning medical tests, from November 2 (Mon.), 2020, to short-term overseas business travelers who have returned to or re-entered Japan.

1. Outline of TeCOT

Since October 8 (Thur.), 2020, METI, in collaboration with the Ministry of Health, Labour and Welfare (MHLW), has been operating TeCOT as a system in which overseas business travelers are able to locate and make a reservation at a desired medical institution which provides a medical test for the novel coronavirus and issues a certification for a negative result of the test in a manner tailored to a request from their destination countries.

2. Outline of new measures for addressing resumption of people’s international movement

The government decided to start, from November 1 (Sun.), 2020, new measures targeting Japanese nationals residing in Japan and overseas nationals with the status of residence in Japan in which when they return to or re-enter Japan from their shot-term overseas business trips, they are eligible for a relaxation of the 14-day stay-at-home period following their return to Japan if they satisfy predetermined conditions. In line with this, when such people return to or re-enter Japan from countries or regions falling under Level 2 or lower of the MOFA’s Travel Advice and Warning on Infectious Diseases, such as China, the ROK and Singapore, they are required to: undergo a PCR test or a quantitative antigen test and obtain a certification for a negative result of such a test before leaving Japan to their destination countries or regions; or undergo a PCR test or a quantitative antigen test after having returned to or re-entered Japan.

For details of the measures, visit the websites below.

3. Start of reservation of medical tests using TeCOT for short-term overseas business travelers who have returned to or re-entered Japan

Against this backdrop, from 13:00, November 2 (Mon.), 2020, TeCOT will start provision of services for short-term overseas business travelers who have returned to or re-entered Japan, supporting them to be are able to locate and make a reservation at a desired medical institution in order to undergo a PCR test or a quantitative antigen test.

Division in Charge